McKesson Corporation (NYSE:MCK) will look for M&A. Britt Vitalone, Chief Financial Officer said, "Our capital deployment principles remain firmly in place. We prioritized growth by investing internally and through M&A. Our focus continues to center on the areas of oncology and biopharma services, including the expansion of access affordability and adherence solutions".